Evaluation of growth hormone secretion: provocative testing vs endogenous 24-hour growth hormone profile
- PMID: 3124498
- DOI: 10.1111/j.1651-2227.1987.tb17130.x
Evaluation of growth hormone secretion: provocative testing vs endogenous 24-hour growth hormone profile
Abstract
A total of 55 children underwent hGH provocative testing with two or more provocative agents, and measurement of endogenous 24-hour hGH secretion. Patients were divided into groups according to their peak hGH secretory response to provocative testing and their mean 24-hour hGH concentration. Peak hGH response to provocative testing was significantly greater in control children and in children with hGH neurosecretory dysfunction (GHND) than in the classical hGH deficient group. Mean 24-hour hGH concentration was significantly greater in the control group than in either the classical hGH deficient or GHND groups. Responses to provocative stimuli were intermediate for the GHND group compared to the classical hGH deficient and the control groups. The mean peak hGH secretory response to insulin-induced hypoglycaemia in the GHND group was poor compared to controls and was greatest following clonidine. The mean peak hGH response to an intravenous bolus of growth hormone releasing hormone was intermediate for the GHND group compared to hGH deficient and control groups. Highest nocturnal peak, first hGH pulse after sleep, mean peak hGH pulse and total number of pulses were also intermediate for the GHND group compared to the other groups. The control group had significantly more pulses greater than 5 ng/ml than did the other groups. Night-time and daytime hGH pools were lower in the classical hGH deficient and GHND groups compared to controls; however, there was overlap between groups. Six of seven children in the GHND group have responded to exogenous hGH therapy with increased linear growth velocity. Measurements of endogenous 24-hour hGH secretion may identify a subgroup of hGH deficient children who are not detected by provocative testing yet who may respond to exogenous hGH therapy with improved linear growth.
Similar articles
-
Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.J Clin Endocrinol Metab. 1986 Sep;63(3):709-16. doi: 10.1210/jcem-63-3-709. J Clin Endocrinol Metab. 1986. PMID: 3525601
-
Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.J Clin Endocrinol Metab. 1986 Oct;63(4):968-73. doi: 10.1210/jcem-63-4-968. J Clin Endocrinol Metab. 1986. PMID: 3018032
-
Human growth hormone (hGH) stimulation tests: the sequential exercise and L-dopa procedure.Clin Endocrinol (Oxf). 1979 Jun;10(6):649-54. doi: 10.1111/j.1365-2265.1979.tb02123.x. Clin Endocrinol (Oxf). 1979. PMID: 476987
-
Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiency.Acta Paediatr Scand Suppl. 1987;331:42-7. doi: 10.1111/j.1651-2227.1987.tb17097.x. Acta Paediatr Scand Suppl. 1987. PMID: 3111168 Review.
-
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications.Drugs. 1991 Feb;41(2):161-77. doi: 10.2165/00003495-199141020-00002. Drugs. 1991. PMID: 1709847 Review.
Cited by
-
GHRH-test in short children with "non classic" GH deficiency. A comparison with "classic" GH deficiency and short normal stature.J Endocrinol Invest. 1990 Jun;13(6):475-80. doi: 10.1007/BF03348603. J Endocrinol Invest. 1990. PMID: 2258576
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical